Exhibit 1.1
MB FINANCIAL, INC.
10,937,500 Shares of Common
Stock, par value $0.01 per share
Underwriting Agreement
September 14, 2009
J.P. Morgan
Securities Inc.
277 Park
Avenue
New York, New
York 10172
As
Representative of the
several
Underwriters listed
in Schedule 1
hereto
Ladies and
Gentlemen:
MB Financial, Inc., a Maryland corporation (the
“Company”), proposes to issue and sell to the several
Underwriters listed in Schedule 1 hereto (the
“Underwriters”), for whom you are acting as
representative (the “Representative”), an aggregate of
10,937,500 shares of common stock, par value $0.01 per share, of
the Company (the “Underwritten Shares”) and, at the
option of the Underwriters, up to an additional 1,640,625 shares of
common stock of the Company (the “Option
Shares”). The Underwritten Shares and the Option
Shares are herein referred to as the
“Shares”. The shares of common stock of the
Company to be outstanding after giving effect to the sale of the
Shares are referred to herein as the
“Stock”.
The Company hereby confirms its agreement with
the several Underwriters concerning the purchase and sale of the
Shares, as follows:
1. Registration
Statement . The Company has prepared and filed with
the Securities and Exchange Commission (the
“Commission”) under the Securities Act of 1933, as
amended, and the rules and regulations of the Commission thereunder
(collectively, the “Securities Act”), a registration
statement (File No. 333-156332), including a prospectus, relating
to the Shares. Such registration statement, as amended
at the time it became effective, including the information, if any,
deemed pursuant to Rule 430A, 430B or 430C under the Securities Act
to be part of the registration statement at the time of its
effectiveness (“Rule 430 Information”), is referred to
herein as the “Registration Statement”; and as used
herein, the term “Preliminary Prospectus” means each
prospectus included in such registration statement (and any
amendments thereto) before effectiveness, any prospectus filed with
the Commission pursuant to Rule 424(a) under the Securities Act and
the prospectus included in the Registration Statement at the time
of its effectiveness that omits Rule 430 Information, and the term
“Prospectus” means the prospectus in the form first
used (or made available upon request of purchasers pursuant to Rule
173 under the Securities Act) in connection with confirmation of
sales of the Shares. If the Company has filed an
abbreviated registration statement pursuant to Rule 462(b) under
the Securities Act (the “Rule 462 Registration
Statement”), then any reference herein to the term
“Registration Statement” shall be deemed to include
such Rule 462 Registration Statement. Any reference in
this Agreement to the Registration Statement, any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and
include the documents incorporated by reference therein pursuant to
Item 12 of Form S-3 under the Securities Act, as of the effective
date of the Registration Statement or the date of such Preliminary
Prospectus or the Prospectus, as the case may be, and any reference
to “amend”, “amendment” or
“supplement” with respect to the Registration
Statement, any Preliminary Prospectus or the Prospectus shall be
deemed to refer to and include any documents filed after such date
under the Securities Exchange Act of 1934, as amended, and the
rules and regulations of the Commission thereunder (collectively,
the “Exchange Act”) that are deemed to be incorporated
by reference therein. Capitalized terms used but not
defined herein shall have the meanings given to such terms in the
Registration Statement and the Prospectus.
At or prior to the Applicable Time
(as defined below), the Company had prepared the following
information (collectively with the pricing information set forth on
Annex B, the “Pricing Disclosure
Package”): a Preliminary Prospectus dated
September 14, 2009 and each “free-writing prospectus”
(as defined pursuant to Rule 405 under the Securities Act) listed
on Annex B hereto.
“Applicable Time” means
9:30 A.M., New York City time, on September 14, 2009.
2. Purchase of the
Shares by the Underwriters .
(a) The Company agrees
to issue and sell the Underwritten Shares to the several
Underwriters as provided in this Agreement, and each Underwriter,
on the basis of the representations, warranties and agreements set
forth herein and subject to the conditions set forth herein,
agrees, severally and not jointly, to purchase from the Company the
respective number of Underwritten Shares set forth opposite such
Underwriter’s name in Schedule 1 hereto at a price per share
(the “Purchase Price”) of $15.20.
In addition, the Company agrees to
issue and sell the Option Shares to the several Underwriters as
provided in this Agreement, and the Underwriters, on the basis of
the representations, warranties and agreements set forth herein and
subject to the conditions set forth herein, shall have the option
to purchase, severally and not jointly, from the Company the Option
Shares at the Purchase Price less an amount per share equal to any
dividends or distributions declared by the Company and payable on
the Underwritten Shares but not payable on the Option
Shares.
If any Option Shares are to be
purchased, the number of Option Shares to be purchased by each
Underwriter shall be the number of Option Shares which bears the
same ratio to the aggregate number of Option Shares being purchased
as the number of Underwritten Shares set forth opposite the name of
such Underwriter in Schedule 1 hereto (or such number increased as
set forth in Section 10 hereof) bears to the aggregate number of
Underwritten Shares being purchased from the Company by the several
Underwriters, subject, however, to such adjustments to eliminate
any fractional Shares as the Representative in its sole discretion
shall make.
The Underwriters may exercise the
option to purchase Option Shares at any time in whole, or from time
to time in part, on or before the thirtieth day following the date
of the Prospectus, by written notice from the Representative to the
Company. Such notice shall set forth the aggregate
number of Option Shares as to which the option is being exercised
and the date and time when the Option Shares are to be delivered
and paid for, which may be the same date and time as the Closing
Date (as hereinafter defined) but shall not be earlier than the
Closing Date or later than the tenth full business day (as
hereinafter defined) after the date of such notice (unless such
time and date are postponed in accordance with the provisions of
Section 10 hereof). Any such notice shall be given at
least two business days prior to the date and time of delivery
specified therein.
(b) The Company
understands that the Underwriters intend to make a public offering
of the Shares as soon after the effectiveness of this Agreement as
in the judgment of the Representative is advisable, and initially
to offer the Shares on the terms set forth in the
Prospectus. The Company acknowledges and agrees that the
Underwriters may offer and sell Shares to or through any affiliate
of an Underwriter.
(c) Payment for the
Shares shall be made by wire transfer in immediately available
funds to the account specified by the Company to the Representative
in the case of the Underwritten Shares, at the offices of Davis
Polk & Wardwell LLP at 10:00 A.M., New York City time, on
September 17, 2009, or at such other time or place on the same or
such other date, not later than the fifth business day thereafter,
as the Representative and the Company may agree upon in writing or,
in the case of the Option Shares, on the date and at the time and
place specified by the Representative in the written notice of the
Underwriters’ election to purchase such Option
Shares. The time and date of such payment for the
Underwritten Shares is referred to herein as the “Closing
Date”, and the time and date for such payment for the Option
Shares, if other than the Closing Date, is herein referred to as
the “Additional Closing Date”.
Payment for the Shares to be
purchased on the Closing Date or the Additional Closing Date, as
the case may be, shall be made against delivery to the
Representative for the respective accounts of the several
Underwriters of the Shares to be purchased on such date or the
Additional Closing Date, as the case may be, with any transfer
taxes payable in connection with the sale of such Shares duly paid
by the Company. Delivery of the Shares shall be made
through the facilities of The Depository Trust Company
(“DTC”) unless the Representative shall otherwise
instruct. The certificates, if any, for the Shares will
be made available for inspection and packaging by the
Representative at the office of DTC or its designated custodian not
later than 1:00 P.M., New York City time, on the business day prior
to the Closing Date or the Additional Closing Date, as the case may
be.
(d) The Company
acknowledges and agrees that the Underwriters are acting solely in
the capacity of an arm’s length contractual counterparty to
the Company with respect to the offering of Shares contemplated
hereby (including in connection with determining the terms of the
offering) and not as a financial advisor or a fiduciary to, or an
agent of, the Company or any other person. Additionally,
neither the Representative nor any other Underwriter is advising
the Company or any other person as to any legal, tax,
investment, accounting or regulatory matters in any
jurisdiction. The Company shall consult with its own
advisors concerning such matters and shall be responsible for
making its own independent investigation and appraisal of the
transactions contemplated hereby, and the Underwriters shall have
no responsibility or liability to the Company with respect
thereto. Any review by the Underwriters of the Company,
the transactions contemplated hereby or other matters relating to
such transactions will be performed solely for the benefit of the
Underwriters and shall not be on behalf of the Company.
3. Representations
and Warranties of the Company . The Company
represents and warrants to each Underwriter that:
(a) Preliminary
Prospectus. No order preventing or suspending the
use of any Preliminary Prospectus has been issued by the
Commission, and each Preliminary Prospectus included in the Pricing
Disclosure Package, at the time of filing thereof, complied in all
material respects with the Securities Act, and no Preliminary
Prospectus, at the time of filing thereof, contained any untrue
statement of a material fact or omitted to state a material fact
necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading;
provided that the Company makes no representation and
warranty with respect to any statements or omissions made in
reliance upon and in conformity with information relating to any
Underwriter furnished to the Company in writing by such Underwriter
through the Representative expressly for use in any Preliminary
Prospectus, it being understood and agreed that the only such
information furnished by any Underwriter consists of the
information described as such in Section 7(b) hereof.
(b) Pricing
Disclosure Package . The Pricing Disclosure Package
as of the Applicable Time did not, and as of the Closing Date and
as of the Additional Closing Date, as the case may be, will not,
contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading; provided that the Company makes no
representation and warranty with respect to any statements or
omissions made in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representative expressly for use in
such Pricing Disclosure Package, it being understood and agreed
that the only such information furnished by any Underwriter
consists of the information described as such in Section 7(b)
hereof.
(c) Issuer Free
Writing Prospectus. Other than the Registration
Statement, the Preliminary Prospectus and the Prospectus, the
Company (including its agents and representatives, other than the
Underwriters in their capacity as such) has not prepared, used,
authorized, approved or referred to and will not prepare, use,
authorize, approve or refer to any “written
communication” (as defined in Rule 405 under the Securities
Act) that constitutes an offer to sell or solicitation of an offer
to buy the Shares (each such communication by the Company or its
agents and representatives (other than a communication referred to
in clause (i) below) an “Issuer Free Writing
Prospectus”) other than (i) any document not constituting a
prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or
Rule 134 under the Securities Act or (ii) the documents listed on
Annex B hereto, each electronic road show and any other written
communications approved in writing in advance by the
Representative. Each such Issuer Free Writing Prospectus
complied in all material respects with the Securities Act, has been
or will be (within the time period specified in Rule 433) filed in
accordance with the Securities Act (to the extent required thereby)
and, when taken together with the Preliminary Prospectus
accompanying, or delivered prior to delivery of, such Issuer Free
Writing Prospectus, did not, and as of the Closing Date and as of
the Additional Closing Date, as the case may be, will not, contain
any untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; provided that the Company makes no
representation and warranty with respect to any statements or
omissions made in each such Issuer Free Writing Prospectus or
Preliminary Prospectus in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in
writing by such Underwriter through the Representative expressly
for use in such Issuer Free Writing Prospectus or Preliminary
Prospectus, it being understood and agreed that the only such
information furnished by any Underwriter consists of the
information described as such in Section 7(b) hereof.
(d) Registration
Statement and Prospectus. The Registration
Statement is an “automatic shelf registration
statement” as defined under Rule 405 of the Securities Act
that has been filed with the Commission not earlier than three
years prior to the date hereof; and no notice of objection of the
Commission to the use of such registration statement or any
post-effective amendment thereto pursuant to Rule 401(g)(2) under
the Securities Act has been received by the Company. No
order suspending the effectiveness of the Registration Statement
has been issued by the Commission, and no proceeding for that
purpose or pursuant to Section 8A of the Securities Act against the
Company or related to the offering of the Shares has been initiated
or threatened by the Commission; as of the applicable effective
date of the Registration Statement and any post-effective amendment
thereto, the Registration Statement and any such post-effective
amendment complied and will comply in all material respects with
the Securities Act, and did not and will not contain any untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the
statements therein not misleading; and as of the date of the
Prospectus and any amendment or supplement thereto and as of the
Closing Date and as of the Additional Closing Date, as the case may
be, the Prospectus will not contain any untrue statement of a
material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided that
the Company makes no representation and warranty with respect to
any statements or omissions made in reliance upon and in conformity
with information relating to any Underwriter furnished to the
Company in writing by such Underwriter through the Representative
expressly for use in the Registration Statement and the Prospectus
and any amendment or supplement thereto, it being understood and
agreed that the only such information furnished by any Underwriter
consists of the information described as such in Section 7(b)
hereof.
(e) Incorporated
Documents. The documents incorporated by reference
in the Registration Statement, the Prospectus and the Pricing
Disclosure Package, when they were filed with the Commission
conformed in all material respects to the requirements of the
Exchange Act, and none of such documents contained any untrue
statement of a material fact or omitted to state a material fact
necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and any
further documents so filed and incorporated by reference in the
Registration Statement, the Prospectus or the Pricing Disclosure
Package, when such documents are filed with the Commission, will
conform in all material respects to the requirements of the
Exchange Act and will not contain any untrue statement of a
material fact or omit to state a material fact necessary to make
the statements therein, in the light of the circumstances under
which they were made, not misleading.
(f) Financial
Statements. The financial statements (including the
related notes thereto) of the Company and its consolidated
subsidiaries included or incorporated by reference in
the Registration Statement, the Pricing Disclosure Package and the
Prospectus comply in all material respects with the applicable
requirements of the Securities Act and the Exchange Act, as
applicable, and present fairly the financial position of the
Company and its consolidated subsidiaries as of the dates indicated
and the results of their operations and the changes in their cash
flows for the periods specified; such financial statements have
been prepared in conformity with generally accepted accounting
principles in the United States applied on a consistent basis
throughout the periods covered thereby, and any supporting
schedules included or incorporated by reference in the Registration
Statement present fairly the information required to be stated
therein; the other financial information included or incorporated
by reference in the Registration Statement, the Pricing Disclosure
Package and the Prospectus has been derived from the accounting
records of the Company and its consolidated subsidiaries and
presents fairly the information shown thereby.
(g) No Material
Adverse Change. Since the date of the most recent
financial statements of the Company included or incorporated by
reference in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, (i) there has not been any change in
the capital stock (other than the issuance of shares of common
stock upon exercise of stock options and warrants described as
outstanding in, and the vesting and settlement of and grant of
options and awards under existing equity incentive plans described
in, the Registration Statement, the Pricing Disclosure Package and
the Prospectus), short-term debt or long-term debt of the Company
or any of its subsidiaries, or any dividend or distribution of any
kind declared, set aside for payment, paid or made by the Company
on any class of capital stock except as described in the
Registration Statement, the Pricing Disclosure Package and the
Prospectus, or any material adverse change, or any prospective
material adverse change, in or affecting the business, properties,
management, financial position, stockholders’ equity, results
of operations or prospects of the Company and its subsidiaries
taken as a whole; (ii) neither the Company nor any of its
subsidiaries has entered into any transaction or agreement (whether
or not in the ordinary course of business) that is material to the
Company and its subsidiaries taken as a whole or incurred any
liability or obligation, direct or contingent, that is material to
the Company and its subsidiaries taken as a whole; and (iii)
neither the Company nor any of its subsidiaries has sustained any
loss or interference with its business that is material to the
Company and its subsidiaries taken as a whole and that is either
from fire, explosion, flood or other calamity, whether or not
covered by insurance, or from any labor disturbance or dispute or
any action, order or decree of any court or arbitrator or
governmental or regulatory authority, except in each case as
otherwise disclosed in the Registration Statement, the Pricing
Disclosure Package and the Prospectus.
(h) Organization
and Good Standing. The Company and each of its
subsidiaries have been duly organized and are validly existing and
in good standing under the laws of their respective jurisdictions
of organization, and, in the case of MB Financial Bank, N.A., is of
valid corporate existence as a national bank. The Company and each
of its subsidiaries are duly qualified to do business and are in
good standing in each jurisdiction in which their respective
ownership or lease of property or the conduct of their respective
businesses requires such qualification, and have all power and
authority necessary to own or hold their respective properties and
to conduct the businesses in which they are engaged, except where
the failure to be so qualified or in good standing or have such
power or authority would not, individually or in the aggregate,
have a material adverse effect on the business, properties,
management, financial position, stockholders’ equity, results
of operations or prospects of the Company and its subsidiaries
taken as a whole or on the performance by the Company of its
obligations under this Agreement (a “Material Adverse
Effect”). The Company is duly registered as a bank
holding company under the Bank Holding Company Act of 1956, as
amended (“BHCA”) and is a financial holding company
pursuant to Section 4(l) of the BHCA and meets the applicable
requirements for qualification as such. The subsidiaries
listed on Annex C attached hereto are the only significant
subsidiaries of the Company as defined by Rule 1-02 of Regulation
S-X.
(i)
Capitalization. The Company has an authorized
capitalization as set forth in the Registration Statement, the
Pricing Disclosure Package and the Prospectus under the heading
“Capitalization”; all the outstanding shares of capital
stock of the Company have been duly and validly authorized and
issued and are fully paid and non-assessable and are not subject to
any pre-emptive or similar rights; except as described in or
expressly contemplated by the Pricing Disclosure Package and the
Prospectus, there are no outstanding rights (including, without
limitation, pre-emptive rights), warrants or options to acquire, or
instruments convertible into or exchangeable for, any shares of
capital stock or other equity interest in the Company or any of its
subsidiaries, or any contract, commitment, agreement, understanding
or arrangement of any kind relating to the issuance of any capital
stock of the Company or any such subsidiary, any such convertible
or exchangeable securities or any such rights, warrants or options;
the capital stock of the Company conforms in all material respects
to the description thereof contained in the Registration Statement,
the Pricing Disclosure Package and the Prospectus; and all the
outstanding shares of capital stock or other equity interests of
each subsidiary owned, directly or indirectly, by the Company have
been duly and validly authorized and issued, are fully paid and
non-assessable and are owned directly or indirectly by the Company,
free and clear of any lien, charge, encumbrance, security interest,
restriction on voting or transfer or any other claim of any third
party.
(j) Stock
Options. With respect to the stock options (the
“Stock Options”) granted pursuant to the stock-based
compensation plans of the Company and its subsidiaries (the
“Company Stock Plans”), (i) each grant of a Stock
Option was duly authorized no later than the date on which the
grant of such Stock Option was by its terms to be effective (the
“Grant Date”) by all necessary corporate action,
including, as applicable, approval by the board of directors of the
Company (or a duly constituted and authorized committee thereof)
and any required stockholder approval by the necessary number of
votes or written consents, and the award agreement governing such
grant (if any) was duly executed and delivered by each party
thereto, (ii) each such grant was made in accordance with the terms
of the Company Stock Plans, the Exchange Act and all other
applicable laws and regulatory rules or requirements, including the
rules of the Nasdaq Global Select Market and any other exchange on
which Company securities are traded, and (iii) each such grant
was properly accounted for in accordance with GAAP in the financial
statements (including the related notes) of the Company and
disclosed in the Company's filings with the Commission in
accordance with the Exchange Act and all other applicable laws. The
Company has not knowingly granted, and there is no and has been no
policy or practice of the Company of granting, Stock Options prior
to, or otherwise coordinating the grant of Stock Options with, the
release or other public announcement of material information
regarding the Company or its subsidiaries or their results of
operations or prospects.
(k) Due
Authorization. The Company has full right, power
and authority to execute and deliver this Agreement and to perform
its obligations hereunder; and all action required to be taken for
the due and proper authorization, execution and delivery by it of
this Agreement and the consummation by it of the transactions
contemplated hereby has been duly and validly taken.
(l) Underwriting
Agreement. This Agreement has been duly authorized, executed
and delivered by the Company.
(m) The
Shares. The Shares to be issued and sold by the
Company hereunder have been duly authorized and, when issued and
delivered and paid for as provided herein, will be duly and validly
issued, will be fully paid and nonassessable and will conform in
all material respects to the descriptions thereof in the
Registration Statement, the Pricing Disclosure Package and the
Prospectus; and the issuance of the Shares is not subject to any
preemptive or similar rights.
(n) No Violation or
Default. Neither the Company nor any of its
subsidiaries is (i) in violation of its charter or by-laws or
similar organizational documents; (ii) in default, and no
event has occurred that, with notice or lapse of time or both,
would constitute such a default, in the due performance or
observance of any term, covenant or condition contained in any
indenture, mortgage, deed of trust, loan agreement or other
agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of
the Company or any of its subsidiaries is subject; or (iii) in
violation of any law or statute or any judgment, order, rule or
regulation of any court or arbitrator or governmental or regulatory
authority, except, in the case of clauses (ii) and (iii) above, for
any such default or violation that would not, individually or in
the aggregate, reasonably be expected to have a Material Adverse
Effect.
(o) No
Conflicts. The execution, delivery and performance
by the Company of this Agreement, the issuance and sale of the
Shares and the consummation of the transactions contemplated by
this Agreement will not (i) conflict with or result in a breach or
violation of any of the terms or provisions of, or constitute a
default under, or result in the creation or imposition of any lien,
charge or encumbrance upon any property or assets of the Company or
any of its subsidiaries pursuant to, any indenture, mortgage, deed
of trust, loan agreement or other agreement or instrument to which
the Company or any of its subsidiaries is a party or by which the
Company or any of its subsidiaries is bound or to which any of the
property or assets of the Company or any of its subsidiaries is
subject, (ii) result in any violation of the provisions of the
charter or by-laws or similar organizational documents of the
Company or any of its subsidiaries or (iii) result in the violation
of any law or statute or any judgment, order, rule or
regulation of any court or arbitrator or governmental or regulatory
authority, except, in the case of clauses (i) and (iii) above, for
any such conflict, breach, violation or default that would not,
individually or in the aggregate, have a Material Adverse
Effect.
(p) No Consents
Required. No consent, approval, authorization,
order, license, registration or qualification of or with any court
or arbitrator or governmental or regulatory authority is required
for the execution, delivery and performance by the Company of this
Agreement, the issuance and sale of the Shares and the consummation
of the transactions contemplated by this Agreement, except for the
registration of the Shares under the Securities Act and such
consents, approvals, authorizations, orders and registrations or
qualifications as may be required by the Financial Industry
Regulatory Authority, Inc. (“FINRA”) and under
applicable state securities laws in connection with the purchase
and distribution of the Shares by the Underwriters.
(q) Legal
Proceedings. Except as described in the
Registration Statement, the Pricing Disclosure Package and the
Prospectus, there are no legal, governmental or regulatory
investigations, actions, suits or proceedings pending to which the
Company or any of its subsidiaries is or may be a party or to which
any property of the Company or any of its subsidiaries is or may be
the subject that, individually or in the aggregate, if determined
adversely to the Company or any of its subsidiaries, could
reasonably be expected to have a Material Adverse Effect; no such
investigations, actions, suits or proceedings are threatened or, to
the knowledge of the Company, contemplated by any governmental or
regulatory authority or threatened by others; and (i) there are no
current or pending legal, governmental or regulatory actions, suits
or proceedings that are required under the Securities Act to be
described in the Registration Statement, the Pricing Disclosure
Package or the Prospectus that are not so described in the
Registration Statement, the Pricing Disclosure Package and the
Prospectus and (ii) there are no statutes, regulations or contracts
or other documents that are required under the Securities Act to be
filed as exhibits to the Registration Statement or described in the
Registration Statement, the Pricing Disclosure Package or the
Prospectus that are not so filed as exhibits to the Registration
Statement or described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus.
(r) Independent
Accountants . McGladrey & Pullen LLP, who has
certified certain financial statements of the Company and its
subsidiaries, is an independent registered public accounting firm
with respect to the Company and its subsidiaries within the
applicable rules and regulations adopted by the Commission and the
Public Company Accounting Oversight Board (United States) and as
required by the Securities Act.
(s) Title to Real
and Personal Property . The Company and its
subsidiaries have good and marketable title in fee simple (in the
case of real property) to, or have valid and marketable rights to
lease or otherwise use, all items of real and personal property and
assets that are material to the respective businesses of the
Company and its subsidiaries, in each case free and clear of all
liens, encumbrances, claims and defects and imperfections of title
except those that (i) do not materially interfere with the use made
and proposed to be made of such property by the Company and its
subsidiaries or (ii) could not reasonably be expected, individually
or in the aggregate, to have a Material Adverse Effect.
(t) Title to
Intellectual Property . The Company and its
subsidiaries own or possess adequate rights to use all material
patents, patent applications, trademarks, service marks, trade
names, trademark registrations, service mark registrations,
copyrights, licenses and know-how (including trade secrets and
other unpatented and/or unpatentable proprietary or confidential
information, systems or procedures) necessary for the conduct of
their respective businesses as currently conducted and as proposed
to be conducted, and the conduct of their respective businesses
will not conflict in any material respect with any such rights of
others. The Company and its subsidiaries have not received any
notice of any claim of infringement, misappropriation or conflict
with any such rights of others in connection with its patents,
patent rights, licenses, inventions, trademarks, service marks,
trade names, copyrights and know-how, which could reasonably be
expected to result in a Material Adverse Effect.
(u) No Undisclosed
Relationships . No relationship, direct or indirect,
exists between or among the Company or any of its subsidiaries, on
the one hand, and the directors, officers, stockholders, customers
or suppliers of the Company or any of its subsidiaries, on the
other, that is required by the Securities Act to be described in
the Registration Statement and the Prospectus and that is not so
described in such documents and in the Pricing Disclosure
Package.
(v)
Investment Company Act . The Company is not and,
after giving effect to the offering and sale of the Shares and the
application of the proceeds thereof as described in the
Registration Statement, the Pricing Disclosure Package and the
Prospectus, will not be required to register as an
“investment company” or an entity
“controlled” by an “investment company”
within the meaning of the Investment Company Act of 1940, as
amended, and the rules and regulations of the Commission thereunder
(collectively, the “Investment Company
Act”).
(w) Taxes.
The Company and its subsidiaries have paid all federal,
state, local and foreign taxes and filed all tax returns required
to be paid or filed through the date hereof, except where the
failure to pay such taxes and file such tax returns would not have
a Material Adverse Effect; and except as otherwise disclosed in the
Registration Statement, the Pricing Disclosure Package and the
Prospectus, there is no tax deficiency that has been, or could
reasonably be expected to be, asserted against the Company or any
of its subsidiaries or any of their respective properties or assets
that would have a Material Adverse Effect.
(x) Licenses and
Permits. The Company and its subsidiaries possess
all licenses, certificates, permits and other authorizations issued
by, and have made all declarations and filings with, the
appropriate federal, state, local or foreign governmental or
regulatory authorities that are necessary for the ownership or
lease of their respective properties or the conduct of their
respective businesses as described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, except where the
failure to possess or make the same would not, individually or in
the aggregate, have a Material Adverse Effect; and except as
described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, neither the Company nor any of its
subsidiaries has received notice of any revocation or modification
of any such license, certificate, permit or authorization or has
any reason to believe that any such license, certificate, permit or
authorization will not be renewed in the ordinary course, except
where such revocation, modification or non-renewal would not have a
Material Adverse Effect.
(y) No Labor
Disputes. No labor disturbance by or dispute with
employees of the Company or any of its subsidiaries exists or, to
the knowledge of the Company, is contemplated or threatened, and
the Company is not aware of any existing or imminent labor
disturbance by, or dispute with, the employees of any of its or its
subsidiaries’ principal suppliers, contractors or customers,
except as would not reasonably be expected to have a Material
Adverse Effect.
(z) Compliance with
and Liability under Environmental Laws. (i) The
Company and its subsidiaries (a) are in compliance with any and all
applicable federal, state, local and foreign laws, rules,
regulations, requirements, decisions, judgments, decrees and orders
relating to the protection of the environment, including those
relating to the generation, storage, treatment, use, handling,
transportation, Release or threat of Release of Hazardous Materials
(collectively, “Environmental Laws”), (b) have received
and are in compliance with all permits, licenses, certificates or
other authorizations or approvals required of them under applicable
Environmental Laws to conduct their respective businesses, and (c)
have not received notice of any actual or potential liability under
or relating to, or actual or potential violation of, any
Environmental Laws, and have no knowledge of any event or condition
that would reasonably be expected to result in any such notice, and
(ii) there are no costs or liabilities associated with
Environmental Laws of or relating to the Company or its
subsidiaries, except in the case of each of (i) and (ii) above, for
any such matter, as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect; and (iii)
except as described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, (a) there are no proceedings
that are pending, or that are known by the Company to be
contemplated, against the Company or any of its subsidiaries under
any Environmental Laws in which a governmental entity is also a
party, other than such proceedings regarding which it is reasonably
believed no monetary sanctions of $100,000 or more will be imposed,
(b) the Company and its subsidiaries are not aware of any facts or
issues regarding compliance with Environmental Laws, or liabilities
or other obligations under Environmental Laws, that could
reasonably be expected to have a material effect on the capital
expenditures or earnings of the Company and its subsidiaries, and
(c) none of the Company and its subsidiaries anticipates material
capital expenditures relating to any Environmental
Laws. “Hazardous Material” means any
material, chemical, substance, waste, pollutant, contaminant,
compound, mixture, or constituent thereof, in any form or amount,
including petroleum (including crude oil or any fraction thereof)
and petroleum products, natural gas liquids, asbestos and asbestos
containing materials, naturally occurring radioactive materials,
brine, and drilling mud, regulated or which can give rise to
liability under any Environmental
Law. “Release” means any spilling, leaking,
seepage, pumping, pouring, emitting, emptying, discharging,
injecting, escaping, leaching, dumping, disposing, depositing,
dispersing, or migrating in, into or through the environment, or
in, into from or through any building or structure.
(bb) Compliance with
ERISA. (i) Each employee benefit plan, within the
meaning of Section 3(3) of the Employee Retirement Income Security
Act of 1974, as amended (“ERISA”), for which the
Company or any member of its “Controlled Group”
(defined as any organization which is a member of a controlled
group of corporations within the meaning of Section 414 of the
Internal Revenue Code of 1986, as amended (the “Code”))
would have any liability (each, a “Plan”) has been
maintained in compliance with its terms and the requirements of any
applicable statutes, orders, rules and regulations, including but
not limited to ERISA and the Code, except for noncompliance that
could not reasonably be expected to result in a liability material
to the Company and its subsidiaries taken as a
whole; (ii) no prohibited transaction, within the
meaning of Section 406 of ERISA or Section 4975 of the Code, has
occurred with respect to any Plan excluding transactions effected
pursuant to a statutory or administrative exemption that could
reasonably be expected to result in a liability material to the
Company and its subsidiaries taken as a whole; (iii) for each Plan
that is subject to the funding rules of Section 412 of the Code or
Section 302 of ERISA, the minimum funding standard of Section 412
of the Code or Section 302 of ERISA, as applicable, has been
satisfied (without taking into account any waiver thereof or
extension of any amortization period) and is reasonably expected to
be satisfied in the future (without taking into account any waiver
thereof or extension of any amortization period); (iv) the fair
market value of the assets of each Plan exceeds the present value
of all benefits accrued under such Plan (determined based on those
assumptions used to fund such Plan); (v) no “reportable
event” (within the meaning of Section 4043(c) of ERISA) has
occurred or is reasonably expected to occur that either has
resulted, or could reasonably be expected to result, in liability
material to the Company and its subsidiaries taken as a whole; (vi)
neither the Company nor any member of the Controlled Group has
incurred, nor reasonably expects to incur, any liability under
Title IV of ERISA (other than contributions to the Plan or premiums
to the PBGC, in the ordinary course and without default) in respect
of a Plan (including a “multiemployer plan”, within the
meaning of Section 4001(a)(3) of ERISA); and (vii) there is no
pending audit or investigation by the Internal Revenue Service, the
U.S. Department of Labor, the Pension Benefit Guaranty Corporation
or any other governmental agency or any foreign regulatory agency
with respect to any Plan that could reasonably be expected to
result in liability material to the Company and its subsidiaries
taken as a whole. None of the following events has
occurred or is reasonably likely to occur: (x) a material increase
in the aggregate amount of contributions required to be made to all
Plans by the Company or its subsidiaries in the current fiscal year
of the Company and its subsidiaries compared to the amount of such
contributions made in the Company and its subsidiaries’ most
recently completed fiscal year; or (y) a material increase in the
Company and its subsidiaries’ “accumulated
post-retirement benefit obligations” (within the meaning of
Statement of Financial Accounting Standards 106) compared to the
amount of such obligations in the Company and its
subsidiaries’ most recently completed fiscal year.
(cc) Disclosure
Controls . The Company and its subsidiaries maintain
an effective system of “disclosure controls and
procedures” (as defined in Rule 13a-15(e) of the Exchange
Act) that complies with the requirements of the Exchange Act and
that has been designed to ensure that information required to be
disclosed by the Company in reports that it files or submits under
the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in the Commission’s rules
and forms, including controls and procedures designed to ensure
that such information is accumulated and communicated to the
Company’s management as appropriate to allow timely decisions
regarding required disclosur
|